Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05889117 · ClinicalTrials.gov registry record · NA

Brain Stimulation for Concussion

A NA study of Traumatic Brain Injury and Magnetic Resonance Imaging, sponsored by The Mind Research Network.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT05889117: Active NA study of Traumatic Brain Injury and Magnetic Resonance Imaging, sponsored by The Mind Research Network.

NCT05889117 is a NA study of Traumatic Brain Injury and Magnetic Resonance Imaging that is active but no longer recruiting, run by The Mind Research Network. The registered enrollment target is 15 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05889117, a NA study of Traumatic Brain Injury and Magnetic Resonance Imaging, is active but no longer recruiting, sponsored by The Mind Research Network.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test a new type of magnetic brain stimulation in patients with persistent post-concussive symptoms. Participants will undergo detailed MRI scans before and after 30 treatment sessions (of 3-10 minutes each). The main questions the study aims to answer are: * Will this new type of treatment result in fewer symptoms and better daily functioning? * What are the effects of this treatment on brain functioning?

Primary Outcome

Rivermead post concussion symptoms questionnaire (16 items, rated 0-4, higher number indicating more symptoms, max score of 64; decrease of the score means improvement of symptoms)

Conditions Studied

Traumatic Brain Injury Magnetic Resonance Imaging Post-Concussion Syndrome Transcranial Magnetic Stimulation Neuropsychological Tests

Interventions

  • DEVICE Intermittent theta-burst treatment (iTBS) using MagPro Transcranial Magnetic Stimulator (manufacturer: Magventure)

Study Locations (1)

New Mexico

  • The Mind Research Network - Albuquerque

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-10-30
Est. Completion 2026-05
Phase NA
The Mind Research Network

17 total trials

What the registry record for NCT05889117 still lists

NCT05889117 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (95% lower).

The record links to 5 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Intermittent theta-burst treatment (iTBS) using MagPro Transcranial Magnetic Stimulator (manufacturer: Magventure) is the first listed.

NCT05889117 reports a single indexed study location in New Mexico.

Frequently Asked Questions

What is clinical trial NCT05889117 about?

NCT05889117 is a clinical study titled "Brain Stimulation for Concussion". The goal of this clinical trial is to test a new type of magnetic brain stimulation in patients with persistent post-concussive symptoms. Participants will undergo detailed MRI scans before and after 30 treatment sessions (of 3-10 minutes each). The main questions the study aims to answer are: * Wi...

What is the current status of trial NCT05889117?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2023-10-30. Estimated completion is 2026-05.

What conditions does trial NCT05889117 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Magnetic Resonance Imaging, Post-Concussion Syndrome, Transcranial Magnetic Stimulation, Neuropsychological Tests.

What interventions are being tested in trial NCT05889117?

The interventions under investigation include: Intermittent theta-burst treatment (iTBS) using MagPro Transcranial Magnetic Stimulator (manufacturer: Magventure) (DEVICE).

Who is sponsoring clinical trial NCT05889117?

This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05889117 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05889117's enrollment target sits among peer trials

15 156th of 171 higher than 12 of 171 other Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05889117, the US trial registry maintained by the National Library of Medicine. NCT05889117 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.